CGS, known for its categorical rejection of the most innovative forms of gene therapy has launched a campaign against a procedure that could save thousands of lives and prevent terrible genetic disorders every year. The organization misrepresents the new procedure as a radical departure from current practices–which it is not. In fact, the UK has asked the Human Fertilization and Embryology Authority (HFEA), as the country’s expert independent regulator, to seek public views on whether these techniques should be made available to couples at risk of having an affected child-a cautious and entirely appropriate response to an evolutionary and life-saving development in gene therapy.